Table 1.

Clinical and laboratory characteristics

N	158
Age, years	50 (45, 57)
Male	139 (88)
Caucasian	92 (58.2)
History of hypertension	64 (40.5)
History of diabetes mellitus	8 (5.1)
Current cigarette smoker	39 (24.7)
Former cigarette smoker	65 (41.4)
Body mass index (BMI), kg m−2	25.7 (23.65, 27.88)
Systolic BP, mmHg	121 (114,132)
Diastolic BP, mmHg	75 (69, 81)
RDW, %	13.4 (12.9, 14.1)
Hemoglobin, g L−1	14.5 (13.7, 15.3)
MCV, fL	96.2 (92.68, 99.2)
Platelet, × 109 L−1	198 (172, 233)
Creatinine, mg dL−1	1.0 (0.9, 1.1)
HDL cholesterol, mg dL−1	42 (33, 53)
LDL cholesterol, mg dL−1	108 (89, 132)
Total Cholesterol, mg dL−1	178 (155, 207)
Total/HDL ratio	4.14 (3.42, 5.17)
Triglycerides, mg dL−1	117 (87, 169)
Therapeutic duration on ART, years	12.6 (7.0, 16.2)
HIV RNA <48 copies mL−1 (undetectable viral load)	135 (84.4)
CD4+ T cell count, cells mm−3	503 (341, 661)
CD8+ T cell count, cells mm−3	737 (560, 1033)
CD4/CD8 cell count ratio	0.68 (0.42, 0.98)

All categorical variables are summarized with frequencies and percentages, while continuous variables are displayed as medians = (Q1, Q3).